Stock Ticker

  • Loading stock data...

Merck & Co’s (NYSE:MRK) Lung Cancer Treatment Dominance With Keytruda Challenged By The Likes Of Regeneron

Over the years, Merck & Co’s (NYSE:MRK) blockbuster cancer treatment, Keytruda, has been the standard first-line treatment alternative for most burdensome lung cancers, but this dominance is about to change. Recently at a cancer research conference, several companies challenged the treatment with their won cancer drugs. Merck’s blockbuster cancer treatment could face competition from new […]

Merck (NYSE:MRK) Makes Investment In Seattle Genetics Inc. (NASDAQ:SGEN) For Development Of Ladiratuzumab Vedotin

Merck (NYSE:MRK) has entered a development agreement for Seattle Genetics Inc. (NASDAQ:SGEN) ladiratuzimab vedotin antibody-drug conjugate (ADC). Merck joins Gilead in investing in ADC-developer with a stake in Seattle Genetics The agreement came hours after Gilead Sciences Inc. (NYSE:GILD) announced the acquisition of Immunomedics for $21 billion. The centerpiece of Gilead’s deal is Immunomedic’s anti-Trop-2 […]

Merck & Co., Inc. (NYSE:MRK) Achieves Limited Success Of Steglatro In Reducing The Risk Of Patients With Total Hospitalizations

Merck & Co., Inc.  (NYSE:MRK) reported only limited success in lowering patients’ total hospitalizations with heart failures. According to recent clinical data, Merck’s Steglatro could overall reduce cardiovascular death or total hospitalization risks by just 17% or lower the risk of the patient by 30%. In a statement, Merck said the first hospitalizations rate remains […]

Johnson & Johnson (NYSE:JNJ) Coronavirus Vaccine To Start Late-Stage Trial In September

A coronavirus vaccine being developed by Johnson & Johnson (NYSE:JNJ) is expected to move to late-stage trial in September. In an announcement last week, the company said the phase three study will enroll 60,000 candidates aged 18 and above in around 180 locations in the U.S and abroad. Details released by the company indicate that […]

Stocks to Watch Ahead of the “Twindemic” (APT, LAKE, ALST, DGX)

The pandemic is old news. Scientists and health policy experts are now worried about the rising potential for the “Twindemic” – a coincident crisis involving Covid-19 and influenza primed for emergence this fall as people worry about going to the doctor to get their flu shot. Without widespread adoption of flu shots, the flu could […]

Pfizer Inc.’s (NYSE:PFE) Transforming Into An Integrated and Collaborative Intelligence Company

Over the past decade, Pfizer Inc.’s (NYSE:PFE) data science senior director Chris Kakkanatt has been transforming the company into a collaborative and integrated intelligence entity. This idea has made headlines for years, and with the proliferation of advances and data in machine learning, the objective has become necessary for most organizations. Kakkanatt shared the transformation […]

The Virus Testing Boom is Upon Us (CODX, DGX, RXMD, LH)

Trump even said it himself on Tuesday: “It’s going to get worse before it gets better.” We keep hitting new highs among coronavirus infections, hospitalization, and related deaths. New hot spots keep popping up. Mississippi appears to be the latest. The positivity rate in Arizona continues to be in the 20-40% range, which smacks of […]

OPKO Health’s (NASDAQ:OPK) BioReferences Laboratories Announce COVID-19 Molecular PCR Testing Results In Nursing Home Employees

OPKO Health’s (NASDAQ:OPK) BioReferences Laboratories released results of the coronavirus molecular PCR and antibody tests for the live-in facility and nursing home employees in New York. Around 29% of nursing home staff had COVID-19 before May On May 10, 2020, the state of New York directed all employees in adult care facilities and nursing homes […]

Abbvie Inc (NYSE:ABBV) And Alpine Immune Sciences Inc. (NASDAQ:ALPN) Enter Partnership To Develop ALPN-101

Abbvie Inc (NYSE:ABBV) and Alpine Immune Sciences Inc. (NASDAQ:ALPN) have announced an exclusive global license and option agreement for Alpine’s best in class dual ICOS/CD28 costimulation antagonist, ALPN-101. AbbVie to co-develop ALPN-101 with Alpine ICOS and CD28 are important costimulatory molecules playing critical roles in inflammatory autoimmune diseases. Alpine’s ALPN-101 is a potent ICOS and […]

Eli Lilly And Co (NYSE:LLY) Commences First Human Trial Involving Its Antibody-based COVID-19 Treatment

Eli Lilly And Co (NYSE:LLY) revealed on Monday that it started testing human subjects with its developmental treatment for COVID-19, which is based on antibodies. The biopharma is currently working on phase 1 of the clinical trial, through which it aims to test the safety and efficacy of the drug. Eli Lilly plans to publish […]

Gilead Sciences, Inc. (NASDAQ:GILD) Reports Minor Benefits Of Remdesivir In COVID-19 Patients

Gilead Sciences, Inc. (NASDAQ:GILD) released an update about its developmental COVID-19 vaccine remdesivir, revealing that the treatment yielded modest improvements in patients. Coronavirus patients who were administered with remdesivir intravenously for five days demonstrated moderate improvements. However, the COVID-19 patients that were treated with the drug for 10-days did not yield significant improvements. Remdesivir was […]

Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul

Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock price, but the announcement also yielded some criticism. The U.S-based biotech revealed that the initial results of its coronavirus vaccine were promising. This was enough to encourage positive sentiments regarding […]

Novavax, Inc (NASDAQ:NVAX) Chooses Australia For Its COVID-19 Clinical Trials

The deadly COVID-19 pandemic continues to affect lives globally, with many people hardly affording to pay their house rent. It is frustrating that until no scientific cure to help handle the condition has been established yet. However, any good efforts mean a lot to frustrated people globally. There are reports about another candidate that is […]

Is the PPE Theme Ready to Catch Fire? (APT, LAKE, BLGO, MMM)

The COVID-19 pandemic has forced a reimagining of life in the developed world to a far greater extent than most anything since World War II. As we endure this collective battle, there are few subjects that spark populist anger more than personal protection equipment (PPE) and its lack of availability for frontline workers – not […]